Accumulation of zinc in human atherosclerotic lesions correlates with calcium levels but does not protect against protein oxidation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 5, 2008, Pages 1024-1030

  Stadler, Nadina ^a,b   Stanley, Naomi ^a   Heeneman, Sylvia ^b   Vacata, Vladimir ^c   Daemen, Mat J A P ^b   Bannon, Paul G ^d   Waltenberger, Johannes ^b   Davies, Michael J ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Gemeinschaftspraxis für Laboratoriumsmedizin   (Germany)

^d The Baird Institute Australia   (Australia)

Author keywords

Atherosclerosis; Calcium; Iron; Protein oxidation; Zinc

Indexed keywords

CALCIUM; COPPER; PROTEIN; ZINC;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CORRELATION ANALYSIS; ELECTRON SPIN RESONANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; TISSUE LEVEL;

AGED; AGED, 80 AND OVER; CALCIUM; CAROTID ARTERY DISEASES; CAROTID STENOSIS; COPPER; HUMANS; IRON; MIDDLE AGED; OXIDATION-REDUCTION; PROTEINS; ZINC;

EID: 42149133684     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.162735     Document Type: Article

References (45)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-1478.
3. Stanley N, Stadler N, Woods AA, Bannon PG, Davies MJ. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radic Biol Med. 2006;40:1636-1643.
4. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol. 2004;24:949-954.
5. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation. 1999;99:852-854.
6. de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med. 1999;159:1542-1548.
7. Horwitz LD, Rosenthal EA. Iron-mediated cardiovascular injury. Vasc Med. 1999;4:93-99.
8. Sullivan JL. Iron and sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
9. Girotti AW, Thomas JP, Jordan JE. Inhibitory effect of zinc(II) on free radical lipid peroxidation in erythrocyte membranes. J Free Radic Biol Med. 1985;1:395-401.
10. Wilkins GM, Leake DS. The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett. 1994;341:259-262.
11. Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med. 2001;31:266-274.
12. Lee DH, Folsom AR, Jacobs DR Jr. Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the Iowa Women's Health Study. Am J Clin Nutr. 2005;81:787-791.
13. Singh RB, Gupta UC, Mittal N, Niaz MA, Ghosh S, Rastogi V. Epidemiologic study of trace elements and magnesium on risk of coronary artery disease in rural and urban Indian populations. J Am Coll Nutr. 1997;16:62-67.
14. Alissa EM, Bahjri SM, Ahmed WH, Al-Ama N, Ferns GA. Trace element status in Saudi patients with established atherosclerosis. J Trace Elem Med Biol. 2006;20:105-114.
15. Vlad M, Caseanu E, Uza G, Petrescu M. Concentration of copper, zinc, chromium, iron and nickel in the abdominal aorta of patients deceased with coronary heart disease. J Trace Elem Electrolytes Health Dis. 1994;8:111-114.
16. Gatto LM, Samman S. The effect of zinc supplementation on plasma lipids and low-density lipoprotein oxidation in males. Free Radic Biol Med. 1995;19:517-521.
17. Hughes S, Samman S. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr. 2006;25:285-291.
18. Bishop GM, Dringen R, Robinson SR. Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic Biol Med. 2007;42:1222-1230.
19. Alissa EM, Bahijri SM, Lamb DJ, Ferns GA. The effects of coadministration of dietary copper and zinc supplements on atherosclerosis, antioxidant enzymes and indices of lipid peroxidation in the cholesterol-fed rabbit. Int J Exp Pathol. 2004;85:265-275.
20. Ren M, Rajendran R, Ning P, Tan Kwong Huat B, Choon Nam O, Watt F, Jenner A, Halliwell B. Zinc supplementation decreases the development of atherosclerosis in rabbits. Free Radic Biol Med. 2006;41:222-225.
21. Jenner A, Ren B, Rajendran R, Ning P, Huat BTK, Watt F, Halliwell B. Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radic Biol Med. 2007;42:559-566.
22. Berger M, Rubinraut E, Barshack I, Roth A, Keren G, George J. Zinc reduces intimal hyperplasia in the rat carotid injury model. Atherosclerosis. 2004;175:229-234.
23. Porsch-Ozcurumez M, Langmann T, Heimerl S, Borsukova H, Kaminski WE, Drobnik W, Honer C, Schumacher C, Schmitz G. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux. J Biol Chem. 2001;276:12427-12433.
24. Reiterer G, Toborek M, Hennig B. Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J Nutr. 2004;134:1711-1715.
25. Hennig B, Toborek M, McClain CJ. Antiatherogenic properties of zinc: implications in endothelial cell metabolism. Nutrition. 1996;12:711-717.
26. Connell P, Young VM, Toborek M, Cohen DA, Barve S, McClain CJ, Hennig B. Zinc attenuates tumor necrosis factor-mediated activation of transcription factors in endothelial cells. J Am Coll Nutr. 1997;16:411-417.
27. Hennig B, Meerarani P, Ramadass P, Toborek M, Malecki A, Slim R, McClain CJ. Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition. 1999;15:744-748.
28. Faber BC, Cleutjens KB, Niessen RL, Aarts PL, Boon W, Greenberg AS, Kitslaar PJ, Tordoir JH, Daemen MJ. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res. 2001;89:547-554.
29. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
30. Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J. 1998;333:519-525.
31. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes. 2002;51:2348-2354.
32. Qian M, Liu M, Eaton JW. Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun. 1998;250:385-389.
33. Symons MCR. Chemical and Biochemical Aspects of Electron Spin Resonance Spectroscopy. London: Wiley; 1978.
34. Beattie JH, Kwun IS. Is zinc deficiency a risk factor for atherosclerosis? Br J Nutr. 2004;91:177-181.
35. Vasto S, Mocchegiani E, Candore G, Listi F, Colonna-Romano G, Lio D, Malavolta M, Giacconi R, Cipriano C, Caruso C. Inflammation, genes and zinc in ageing and age-related diseases. Biogerontology. 2006;7:315-327.
36. Faure P, Roussel AM, Richard MJ, Foulon T, Groslambert P, Hadjian A, Favier A. Effect of an acute zinc depletion on rat lipoprotein distribution and peroxidation. Biol Trace Elem Res. 1991;28:135-146.
37. Reiterer G, MacDonald R, Browning JD, Morrow J, Matveev SV, Daugherty A, Smart E, Toborek M, Hennig B. Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr. 2005;135:2114-2118.
38. Paul A, Calleja L, Joven J, Vilella E, Ferre N, Camps J, Girona J, Osada J. Supplementation with vitamin E and/or zinc does not attenuate atherosclerosis in apolipoprotein E-deficient mice fed a high-fat, high-cholesterol diet. Int J Vitam Nutr Res. 2001;71:45-52.
39. Cotton FA, Wilkinson G. Advanced Inorganic Chemistry. New York: Interscience; 1972.
40. Winter WT, Arnott S. Hyaluronic acid: the role of divalent cations in conformation and packing. J Mol Biol. 1977;117:761-784.
41. Parrish RF, Fair WR. Selective binding of zinc ions to heparin rather than to other glycosaminoglycans. Biochem J. 1981;193:407-410.
42. Sterk H, Braun M, Schmut O, Feichtinger H. Investigation of the hyaluronic acid-copper complex by N.M.R. spectroscopy. Carbohydr Res. 1985;145:1-11.
43. Coleman JE. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem. 1992;61:897-946.
44. Tang ZL, Wasserloos K, St Croix CM, Pitt BR. Role of zinc in pulmonary endothelial cell response to oxidative stress. Am J Physiol. 2001;281:L243-249.
45. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997;17:1859-1867.